Antineutrophil cytoplasmic antibodies in myelodysplasia

D R Hull, S A McMillan, I Maeve Rea, Noleen Boyd, Mary F McMullin

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Antibodies to neutrophil cytoplasmic antigens (ANCA) are good serological markers for patients with mainly vasculitic conditions. Two main types of ANCAs have been detected, the first termed cytoplasmic antineutrophil cytoplasmic antibody (cANCA) are mainly associated with patients with Wegener's granulomatosis, the other termed perinuclear antineutrophil cytoplasmic antibody (pANCA) are mainly associated with patients with renal vasculitis, rheumatic and collagen disorders. These antibodies are against various constituents of neutrophil granules. In patients with myelodysplasia, defects in normal granulocyte development are seen. We report a series of twelve patients with myelodysplasia of whom at least four showed a low titre and one a high titre of pANCA. Two of these patients also had demonstrable activity against myeloperoxidase (MPO). None of these patients had any evidence of systemic or cutaneous vasculitis or of any autoimmune disorder. There was no pANCA positivity in an age matched control group.
Original languageEnglish
Pages (from-to)55-57
Number of pages3
JournalThe Ulster Medical Journal
Volume65
Issue number1
Publication statusPublished - May 1996

Fingerprint Dive into the research topics of 'Antineutrophil cytoplasmic antibodies in myelodysplasia'. Together they form a unique fingerprint.

  • Cite this